Delivery Order SPE2DB20D1047-SPE2DB25FF54L
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $24,125.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,568,078,680 tablets of Concerta ER 36mg, a medication used to treat ADHD. The contract is a firm fixed-price, non-set-aside award with a period of performance through April 30, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,298.19 firm fixed-price delivery order is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,666.50 firm fixed-price delivery order is for Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of August 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,974.04 Firm Fixed Price Delivery Order contract is for the supply of Concerta ER Tabs 36mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of June 30, 2025 and is not a set-aside award, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,242.73 delivery order contract is for the supply of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has a firm fixed-price pricing type and an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is a delivery order valued at $37,308.06, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,815.79, is for the delivery of 100 tablets of Concerta ER 54 mg, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price delivery order, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,325.12 Firm Fixed Price Delivery Order contract is for the supply of 4,568,088,839 units of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 1, 2025 and is not set aside for any specific business category....
This federal contract award, valued at $7,883.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,239,274 units of Concerta ER Tabs 27mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price delivery order with a performance period extending through May 14, 2025. Amerisourcebergen holds...
This federal contract award, valued at $7,141.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER 36 mg tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with a period of performance through November 12, 2024. AmerisourceBergen holds a significant...